News & Announcements

Weil Advised Eli Lilly in $5.4B Acquisition of Novartis Animal Health

A Weil team advised Eli Lilly and Company in its acquisition of Novartis Animal Health for approximately $5.4 billion. The transaction closed on January 22, 2015.

The Weil team on this transaction included M&A partners Raymond Gietz and Matthew Gilroy, and associates Megan Pendleton, Joshua Nemser and Kaitlin Descovich (Admitted in New York only); IP partners Charan Sandhu and Elizabeth Weiswasser, and associates Adrienne Baker, Rachel Vigneaux and Claire Comfort; Tax partner Helyn Goldstein and associate Mark Dundon; Benefits partner Amy Rubin and associate Daniel Birnhak; and Real Estate partner Samuel Zylberberg and associates Melissa Meyrowitz and Mallory Owen (not yet admitted to practice).